Delivery Order SPE2DB20D1109-SPE2DB23FP15E
Award Date 5/17/23
Potential Completion Date 5/18/23
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,166.66, is for the delivery of Ondansetron HCL 4 mg tablets. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,652,155 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price delivery order, valued at $3,711.94, has a period of performance through November 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $26,805.03, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract covers the delivery of 4,564,478,867 units of Ondansetron HCL 8 mg tablets to support military healthcare programs. The award is a firm-fixed-price delivery order contract with a completion date of May 3, 2024. This order is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,930.42 delivery order contract is for the supply of 4565111977 - Ondansetron HCL 8 mg Tablets in 30-count packages. The contract has an ultimate completion date of July 11, 2024 and is a firm fixed-price contract type. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,179.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of March 14, 2025, is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30s. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,858.50 fixed-price delivery order is for the supply of 4,562,764,646 units of Ondansetron HCl 8 mg tablets. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,663.88 firm fixed-price delivery order is for the supply of Ondansetron HCL 4 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary...
- This federal contract award, valued at $7,120.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 8 mg Tablets to support federal healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,382.18 firm fixed-price delivery order is for Ondansetron HCL 8 mg tablets and has a completion date of July 26, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as...
- This federal contract award, valued at $2,083.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,148,202 units of the pharmaceutical product Ondansetron HCL 8 mg Tablet, with a completion date of May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...